Russian court imposes $38,000 fine on Alphabet's Google for non-compliance-March 2024-www.financetom.com

Russian court imposes $38,000 fine on Alphabet's Google for non-compliance

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Russian court imposes $38,000 fine on Alphabet's Google for non-compliance

Nov 18, 2024 10:03 PM

MOSCOW, Nov 18 (Reuters) - A Russian district court

fined Alphabet's Google 3.8 million roubles ($38,057)

on Monday for failing to remove banned content.

Russia has for several years ordered foreign technology

platforms to remove content it deems illegal, issuing small, but

persistent fines when it sees failures to comply.

($1 = 99.8500 roubles)

Previous page： Bitdeer Successfully Tests Latest Bitcoin Mining Microchip; Shares Gain Pre-bell Next page： AbbVie's Tavapadon Meets Primary, Secondary Endpoints in Phase 3 Trial as Early Parkinson's Disease Monotherapy

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bitdeer Successfully Tests Latest Bitcoin Mining Microchip; Shares Gain Pre-bell

Oct 3, 2024

08:39 AM EDT, 09/26/2024 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) shares were higher premarket Thursday after the company said it has successfully tested its latest Bitcoin mining chip, Seal02. The company said that Seal02 uses process nodes created in partnership with chipmaker Taiwan Semiconductor Manufacturing ( TSM ) and has exceptional power efficiency. The company said it...

AbbVie's Tavapadon Meets Primary, Secondary Endpoints in Phase 3 Trial as Early Parkinson's Disease Monotherapy

Oct 3, 2024

08:37 AM EDT, 09/26/2024 (MT Newswires) -- AbbVie ( ABBV ) said Thursday topline results from a phase 3 trial of tavapadon as a monotherapy in early Parkinson's disease met its primary endpoint, as well as a key secondary endpoint. The company said patients treated with tavapadon in both dose groups experienced a 'statistically significant reduction (improvement)' from baseline compared...

SaverOne Signs First US Distribution Agreement With Motor Supply

Oct 3, 2024

08:33 AM EDT, 09/26/2024 (MT Newswires) -- SaverOne (SVRE) said Thursday it signed its first distribution agreement in the US with trucking company Motor Supply. The developer of vehicle safety software said the deal allows Motor Supply to distribute its system in 10 US states with at least 37,600 installations expected in the next five years. Shares of SaverOne were...

Century Therapeutics Appoints Chief Scientific Officer, Finance Chief

Oct 3, 2024

08:31 AM EDT, 09/26/2024 (MT Newswires) -- Century Therapeutics ( IPSC ) said Thursday it appointed Chad Cowan chief scientific officer, effective Oct. 1, and Morgan Conn chief financial officer, effective Oct. 14. Cowan previously served as an executive scientific adviser of the company, following the acquisition of Clade Therapeutics in April 2024, where he was founder and CEO. Meanwhile,...